GLTO
Galecto, Inc. Common Stock
stock NASDAQ

galecto biotech is a newly founded company, focused on developing novel drugs for the treatment of fibrosis, inflammation and other serious human diseases. the company's products target galectins, a group of proteins that play important roles in many disorders. galecto biotech's high potency galectin modulators may open new treatment possibilities for many patients. the company, which is located in lund, sweden, is led by top-level scientists and biotech executives.